$TEVA News Article - Fremanezumab Data in The Lancet Demonstrate Clinically Meaningful Reduction in Monthly Migraine Days Versus Placebo for Patients with Difficult-To-Treat Migraine https://marketwirenews.com/news-releases/frem...79808.html
My Twitter: WhyteStocks